Molecular epidemiology of Pseudomonas aeruginosa in intensive care units over a 10-year period (1998-2007). 2011

M Cuttelod, and L Senn, and V Terletskiy, and I Nahimana, and C Petignat, and P Eggimann, and J Bille, and G Prod'hom, and G Zanetti, and D S Blanc
Hospital Preventive Medicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland.

Pseudomonas aeruginosa is one of the leading nosocomial pathogens in intensive care units (ICUs). The source of this microorganism can be either endogenous or exogenous. The proportion of cases as a result of transmission is still debated, and its elucidation is important for implementing appropriate control measures. To understand the relative importance of exogenous vs. endogenous sources of P. aeruginosa, molecular typing was performed on all available P. aeruginosa isolated from ICU clinical and environmental specimens in 1998, 2000, 2003, 2004 and 2007. Patient samples were classified according to their P. aeruginosa genotypes into three categories: (A) identical to isolate from faucet; (B) identical to at least one other patient sample and not found in faucet; and (C) unique genotype. Cases in categories A and B were considered as possibly exogenous, and cases in category C as possibly endogenous. A mean of 34 cases per 1000 admissions per year were found to be colonized or infected by P. aeruginosa. Higher levels of faucet contamination were correlated with a higher number of cases in category A. The number of cases in category B varied from 1.9 to 20 cases per 1000 admissions. This number exceeded 10/1000 admissions on three occasions and was correlated with an outbreak on one occasion. The number of cases considered as endogenous (category C) was stable and independent of the number of cases in categories A and B. The present study shows that repeated molecular typing can help identify variations in the epidemiology of P. aeruginosa in ICU patients and guide infection control measures.

UI MeSH Term Description Entries
D007362 Intensive Care Units Hospital units providing continuous surveillance and care to acutely ill patients. ICU Intensive Care Units,Intensive Care Unit,Unit, Intensive Care
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D003428 Cross Infection Any infection which a patient contracts in a health-care institution. Hospital Infections,Nosocomial Infections,Health Care Associated Infection,Health Care Associated Infections,Healthcare Associated Infections,Infection, Cross,Infections, Hospital,Infections, Nosocomial,Cross Infections,Healthcare Associated Infection,Hospital Infection,Infection, Healthcare Associated,Infection, Hospital,Infection, Nosocomial,Infections, Cross,Infections, Healthcare Associated,Nosocomial Infection
D004783 Environmental Microbiology The study of microorganisms living in a variety of environments (air, soil, water, etc.) and their pathogenic relationship to other organisms including man. Microbiology, Environmental
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences
D017720 Molecular Epidemiology The application of molecular biology to the answering of epidemiological questions. The examination of patterns of changes in DNA to implicate particular carcinogens and the use of molecular markers to predict which individuals are at highest risk for a disease are common examples. Epidemiology, Molecular,Genetic Epidemiology,Epidemiologies, Genetic,Epidemiologies, Molecular,Epidemiology, Genetic,Genetic Epidemiologies,Molecular Epidemiologies
D058889 Molecular Typing Using MOLECULAR BIOLOGY techniques, such as DNA SEQUENCE ANALYSIS; PULSED-FIELD GEL ELECTROPHORESIS; and DNA FINGERPRINTING, to identify, classify, and compare organisms and their subtypes. Typing, Molecular

Related Publications

M Cuttelod, and L Senn, and V Terletskiy, and I Nahimana, and C Petignat, and P Eggimann, and J Bille, and G Prod'hom, and G Zanetti, and D S Blanc
January 2007, The open microbiology journal,
M Cuttelod, and L Senn, and V Terletskiy, and I Nahimana, and C Petignat, and P Eggimann, and J Bille, and G Prod'hom, and G Zanetti, and D S Blanc
June 2003, Annales francaises d'anesthesie et de reanimation,
M Cuttelod, and L Senn, and V Terletskiy, and I Nahimana, and C Petignat, and P Eggimann, and J Bille, and G Prod'hom, and G Zanetti, and D S Blanc
July 2004, International journal of hygiene and environmental health,
M Cuttelod, and L Senn, and V Terletskiy, and I Nahimana, and C Petignat, and P Eggimann, and J Bille, and G Prod'hom, and G Zanetti, and D S Blanc
June 1993, Epidemiology and infection,
M Cuttelod, and L Senn, and V Terletskiy, and I Nahimana, and C Petignat, and P Eggimann, and J Bille, and G Prod'hom, and G Zanetti, and D S Blanc
January 1988, Annales de biologie clinique,
M Cuttelod, and L Senn, and V Terletskiy, and I Nahimana, and C Petignat, and P Eggimann, and J Bille, and G Prod'hom, and G Zanetti, and D S Blanc
May 2000, Journal of clinical microbiology,
M Cuttelod, and L Senn, and V Terletskiy, and I Nahimana, and C Petignat, and P Eggimann, and J Bille, and G Prod'hom, and G Zanetti, and D S Blanc
January 2020, Frontiers in public health,
M Cuttelod, and L Senn, and V Terletskiy, and I Nahimana, and C Petignat, and P Eggimann, and J Bille, and G Prod'hom, and G Zanetti, and D S Blanc
January 2001, Scandinavian journal of infectious diseases,
M Cuttelod, and L Senn, and V Terletskiy, and I Nahimana, and C Petignat, and P Eggimann, and J Bille, and G Prod'hom, and G Zanetti, and D S Blanc
August 2001, Intensive care medicine,
M Cuttelod, and L Senn, and V Terletskiy, and I Nahimana, and C Petignat, and P Eggimann, and J Bille, and G Prod'hom, and G Zanetti, and D S Blanc
June 2009, Transplant infectious disease : an official journal of the Transplantation Society,
Copied contents to your clipboard!